Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.420,64
0,13%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PTC Therapeutics Inc (PTCT) PTC Therapeutics Inc (PTCT) Notizie

PTC Therapeutics Inc

PTCT
36,52
-0,41 (-1,11%)
08 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/5/202414:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
28/5/202414:30PRNUSPTC Therapeutics Announces Validation of Sepiapterin..
24/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202416:12EDGAR2Form 144 - Report of proposed sale of securities
20/5/202418:20PRNUSPTC Therapeutics Announces European Commission Returns..
20/5/202413:20EDGAR2Form 8-K - Current report
20/5/202413:00PRNUSPTC Therapeutics Announces European Commission Returns..
14/5/202413:30PRNUSPTC Therapeutics Announces FDA Acceptance and Priority..
10/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202421:30EDGAR2Form 144 - Report of proposed sale of securities
02/5/202414:00PRNUSPTC Therapeutics to Participate at Upcoming Investor..
25/4/202422:05PRNUSPTC Therapeutics Provides Corporate Update and Reports First..
23/4/202422:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
11/4/202414:00PRNUSPTC Therapeutics to Host Conference Call to Discuss First..
28/3/202413:30PRNUSPTC Announces Submission of Sepiapterin MAA for Treatment of..
19/3/202412:30PRNUSPTC Therapeutics Provides Key Regulatory Updates
29/2/202422:05PRNUSPTC Therapeutics Provides Corporate Update and Reports..
27/2/202423:20PRNUSPTC Therapeutics to Participate at Upcoming Investor..
22/2/202422:30PRNUSPTC Therapeutics Reports Inducement Grants Under Nasdaq..
16/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202414:00PRNUSPTC Therapeutics to Host Conference Call to Discuss Fourth..
14/2/202421:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202413:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/1/202421:30EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:25EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:18EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:18EDGAR2Form 144 - Report of proposed sale of securities
30/1/202421:17EDGAR2Form 144 - Report of proposed sale of securities
25/1/202422:06EDGAR2Form 8-K - Current report
Apertura: 36,77 Min: 36,22 Max: 37,29
Chiusura: 36,93

La tua Cronologia

NASDAQ
PTCT
PTC Therapeutics
LSE
BW60
Sg Issuer 34
BIT
UB7RXF
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network